You are visiting us from Virginia. You are located in HHS Region 3. Your Center is Central East ATTC.

Products and Resources Catalog

Center
Product Type
Target Audience
Language
Keywords
Date Range
Print Media
Fact sheet that provides an overview of the latest research supporting the effectiveness of the FDA-approved medications for treatment of opioid use disorders.
Published: February 1, 2018
Print Media
Fact sheet on how to respond to concerns about diversion of medications prescribed for treating opioid use disorders.
Published: February 1, 2018
Print Media
This is a one-page flyer detailing the objectives, mission and contact information of the South Africa HIV ATTC.
Published: January 17, 2018
Curriculum Package
Treatment Strategies for Prescription Opioid Dependence is a package of tools and training resources for substance use disorders treatment providers. The results of the study have implications for the treatment of adults dependent on prescription opioids. The POATS Blending Team (BT) package is designed to help treatment providers incorporate study findings and recommendations into their practice.          
Published: January 1, 2018
Curriculum Package
The Buprenorphine Treatment for Young Adults Blending Team designed a training package which highlights the findings of the NIDA CTN study that compared longer term versus short-term buprenorphine/naloxone treatment in an outpatient setting. The 3-hour training program examines the prevalence of and treatment admission rates for nonmedical use of opioids among young adults; provides an overview of opioid use among young adults; explores and increases understanding of the results of new research on using buprenorphine to treat opioid addiction in young adults; and describes the implications of these findings for the treatment of opioid addiction in young adults.        
Published: January 1, 2018
Website
Motivational Incentives-A Proven Approach to Treatment is a collection of products which offer tools needed to learn about and use Motivational Incentives. Also, referred to as Contingency Management, Motivational Incentives has been subject to decades of research in the addiction treatment field; beginning in the 1960s. This collection of products assists organizations along a continuum from raising awareness about Motivational Incentives through dissemination and implementation activities.   What will you find at BetterTxOutcomes.org? Promoting Awareness of Motivational Incentives (PAMI) is an introductory training that exposes organizations to the principles of Motivational Incentives and demonstrates evidence of clinical effectiveness. Behavioral healthcare practitioners can then deepen their knowledge about Motivational Incentives through participating in the free, self-guided, interactive on-line course, Motivational Incentives: Positive Reinforcers to Enhance Successful Treatment Outcomes (MI:PRESTO).      
Published: January 1, 2018
Curriculum Package
The Short-term Opioid Withdawal Using Buprenorphine (Bup Detox) Blending Team designed a training package to instruct treatment providers on the administration of aBup Detox Brochure Cover unique,13-day Buprenorphine taper intervention for opioid dependent patients. Research conducted in both inpatient and outpatient settings by the NIDA Clinical Trials Network demonstrated that, in contrast with the clonidine treatment group, patients receiving Buprenorphine provided more opioid-negative urine samples upon completion of the intervention. This training assumes some basic prior information about what Buprenorphine is and how it is used.            
Published: January 1, 2018
Print Media
Two-page fact sheet with facts about Marijuana and its use as well as its effects on the body, tips for cutting back, and helpful links.
Published: January 1, 2018
Curriculum Package
This 8-hour self-paced course is based on the transdisciplinary foundations of the Substance Abuse and Mental Health Services Administration's Technical Assistance Publication #21, Addiction Counseling Competencies. Designed to provide an overview of the addictive process and basic knowledge, attitudes, and skills utilized by professionals from a variety of backgrounds who work with clients experiencing substance use disorders.
Published: January 1, 2018
Presentation Slides
This presentation had four objective. (1) Detail the scope of the problem. (2) Describe why adolescence is a key period in the pathogenesis of addiction. (3) Explain the prevalence and clinical importance of co-occurring disorders. (4) Review evidence-based interventions & recommendations for improving treatment. Presented by Robert Miranda, Ph.D.
Published: October 11, 2017
Curriculum Package
Self-paced course designed to enhance professional knowledge of MAT and build skills for educating patients about MAT.
Published: October 1, 2017
Presentation Slides
This multidisciplinary six-module training series provides information about the use of medication-assisted treatment for opioid use disorders.
Published: August 5, 2017
Presentation Slides
This presentation discussed trauma-informed approaches to the assessment and treatment of adolescent substance use. Presented by Kay Jankowski, Ph.D.
Published: July 20, 2016
Multimedia
Dr. Thomas E. Freese, Director of the Pacific Southwest ATTC, explains what is meant by "medical" marijuana, who uses it and why, and the difference between medical marijuana and FDA approved medications.
Published: July 31, 2015
Website
Q&A with marijuana expert Dr. Kevin Hill. Topics include Addiction/dependency, adolescence, effects on the body, medical marijuana, potency, and withdrawal.
Published: June 8, 2015
Multimedia
Dr. Laura Borgelt, Professor at the University of Colorado Skaggs School of Pharmacy, discusses the effects marijuana use can have on women who are pregnant, breastfeeding, the unborn child, and newborns.
Published: May 4, 2015
Presentation Slides
This presentation discussed challenges and opportunities working with adolescents with substance use disorders, with a focus on continuity of care. Presented by Yifrah Kaminer, M.D.
Published: April 16, 2015
Multimedia
Dr. Kari Franson from the University of Colorado's Skaggs School of Pharmacy and Pharmaceutical Sciences shares information on the long-term negative outcomes marijuana use has on developing adolescents.
Published: March 25, 2015
Presentation Slides
Dr. Wilson M. Compton, Deputy Director at NIDA, highlights the adverse effects of marijuana use can have on the brain, heart, and respiratory. The video also provides some information on second hand exposure and current marijuana potency.
Published: January 28, 2015
Print Media
Eight, 1-page color infographics (Four in English, four in Spanish) covering 1) Effects on the body 2) Use and educational outcomes, 3) Effects on pregnancy and newborns, and 4) Medical use.
Published: January 1, 2015
eNewsletter or Blog
Dr. Yifrah Kaminer from the University of Connecticut Health gives an overview of the latest research on the marijuana's effects on the brain and how legalization affects states' SUD treatment and prevention systems.
Published: January 1, 2015
Presentation Slides
This training presentation provides information about the use of Buprenorphine in medication-assisted treatment for opioid use disorders.
Published: November 26, 2014
Curriculum Package, Multimedia, Other, Print Media
The purpose of this half-day, introductory training is to provide HIV clinicians (including, but not limited to physicians, dentists, nurses, and other allied medical staff, therapists and social workers, and counselors, specialists, and case managers) with an overview of medical marijuana, its use among individuals living with HIV, and strategies on how to work with HIV patients who are using medical marijuana.
Published: August 9, 2013
Print Media
This book comprises 20 essays in which family members described, in their own words, the most challenging part about having a family member with a substance use disorder, what it means to have a loved one find long-term recovery and explain why they are committed to recovery.
Published: January 13, 2011
1 2 3

The ATTC Network understands that words have power. A few ATTC products developed prior to 2017 may contain language that does not reflect the ATTCs’ current commitment to using affirming, person-first language. We appreciate your patience as we work to gradually update older materials. For more information about the importance of non-stigmatizing language, see “Destroying Addiction Stigma Once and For All: It’s Time” from the ATTC Network and “Changing Language to Change Care: Stigma and Substance Use Disorders” from the Providers Clinical Support System (PCSS).

map-markermagnifiercrossmenuchevron-down